Early increase in α-fetoprotein for predicting unfavorable clinical outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib-Reference-Cited by-同舟云学术

Early increase in α-fetoprotein for predicting unfavorable clinical outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib

Published:2013-06 Issue:6 Volume:25 Page:683-689
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:European Journal of Gastroenterology & Hepatology

Author:

Nakazawa Takahide,Hidaka Hisashi,Takada Juichi,Okuwaki Yusuke,Tanaka Yoshiaki,Watanabe Masaaki,Shibuya Akitaka,Minamino Tsutomu,Kokubu Shigehiro,Koizumi Wasaburo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Intrahepatic Recurrence After Curative Resection of Hepatocellular Carcinoma

2. Radiofrequency Ablation of Hepatocellular Carcinoma: Correlation Between Local Tumor Progression After Ablation and Ablative Margin

3. Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: Risk factors and patterns

4. Repeat Radiofrequency Ablation Provides Survival Benefit in Patients With Intrahepatic Distant Recurrence of Hepatocellular Carcinoma

5. Overall Survival After Transarterial Lipiodol Infusion Chemotherapy With or Without Embolization for Unresectable Hepatocellular Carcinoma: Propensity Score Analysis

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening, Surveillance, and Prevention of Hepatocellular Carcinoma;Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e;2024-01-23

2. Radiographic and serologic response in patients with unresectable hepatocellular carcinoma receiving systemic antineoplastic treatments: A trial‐level analysis;Cancer;2024-01-17

3. The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma—Literature Review;International Journal of Molecular Sciences;2023-05-26

4. CircFAM114A2 inhibits the progression of hepatocellular carcinoma via miR‐630/HHIP axis;Cancer Medicine;2023-04-11

5. Association between posttreatment α‐fetoprotein reduction and outcomes in real‐world US patients with advanced hepatocellular carcinoma;Cancer;2023-03-21